Similar articles

• Update of hepatotoxicity due to classes of drugs in common clinical use: non-steroidal drugs, anti-inflammatory drugs, antibiotics, antihypertensives, and cardiac and psychotropic agents.

  Zimmerman HJ. Zimmerman HJ. Semin Liver Dis. 1990 Nov;10(4):322-38. doi: 10.1055/s-2008-1040488. Semin Liver Dis. 1990. PMID: 2281340 Review. No abstract available.
• [Chronic active hepatitis due to bendazac].

  Rodríguez Rodríguez E, Prieto de Paula JM, Cancelo Suárez P, Echevarría Iturbe C. Rodríguez Rodríguez E, et al. Rev Clin Esp. 1994 Aug;194(8):657-8. Rev Clin Esp. 1994. PMID: 7938854 Review. Spanish. No abstract available.
• [Cholestatic hepatitis associated with tenoxicam].

  Pascual AF, Jiménez Martos F, Rodríguez Moreno C. Pascual AF, et al. Aten Primaria. 1995 Mar 31;15(5):329. Aten Primaria. 1995. PMID: 7734692 Spanish. No abstract available.
• [The hepatotoxic effect of nonsteroidal anti-inflammatory preparations].

  Polunina TE, Fomichev VI, Vasil'ev AP. Polunina TE, et al. Ter Arkh. 1994;66(5):79-80. Ter Arkh. 1994. PMID: 7940350 Russian. No abstract available.
• [Adverse effects of non-steroidal anti-inflammatory drugs].

  Guzecka E, Czarnecki A. Guzecka E, et al. Pol Tyg Lek. 1988 Jul 18;43(29):931-6. Pol Tyg Lek. 1988. PMID: 2976932 Polish. No abstract available.